RadioPharm Theranostics

Carlton South, Australia

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

$5.0M raised

Jan 2025

Post-IPO Equity

Biotechnology Consulting Pharmaceutical Therapeutics

Top Investors

Lantheus Holdings Radium Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about RadioPharm Theranostics

How much funding has RadioPharm Theranostics raised?

RadioPharm Theranostics has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2025.

Who are RadioPharm Theranostics's investors?

RadioPharm Theranostics's investors include Lantheus Holdings, Radium Capital.

Where is RadioPharm Theranostics headquartered?

RadioPharm Theranostics is headquartered in Carlton South, Australia.

What does RadioPharm Theranostics do?

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

What stage is RadioPharm Theranostics at?

RadioPharm Theranostics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2025.

MLA

"RadioPharm Theranostics — Funding & Investors." VCBacked, January 9, 2025, https://www.vcbacked.co/company/radiopharm-theranostics. Accessed July 2, 2026.

APA

VCBacked. (2025). RadioPharm Theranostics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/radiopharm-theranostics

Wikipedia (cite web)

{{cite web |title=RadioPharm Theranostics — Funding & Investors |url=https://www.vcbacked.co/company/radiopharm-theranostics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2025.